Email this article Ascites, spontaneous bacterial peritonitis, hepatorenal syndrome: What is common in their diagnosis and treatment?
- Authors: Bakulin IG1, Varlamicheva AA1
-
Affiliations:
- Issue: Vol 87, No 4 (2015)
- Pages: 77-83
- Section: Editorial
- URL: https://ter-arkhiv.ru/0040-3660/article/view/31752
- ID: 31752
Cite item
Full Text
Abstract
Complications of cirrhosis are a main cause of death in the immediate and late follow-up periods in these patients. Portal hypertension, edematous-ascitic syndrome, spontaneous bacterial peritonitis, hepatorenal syndrome, and hepatic encephalopathy are poor predictors. The sociomedical importance of these complications is obvious for reasons of the high risk of death in these patients in the immediate period (15—30 days). This review represents a set of practical algorithms whose basis is the most effective methods to diagnose, treat, and prevent complications of cirrhosis.
References
- EASL clinical practice guidelines on the management of ascites, spontaneous peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 2010; 53: 397—417.
- Ивашкин В.Т., Маевская М.В. Лечение осложнений цирроза печени: методические рекомендации для врачей. М: Литтерра 2011: 23—35.
- Garcia-Tsao G., Parikh C.R., Viola A. Acute kidney injury in cirrhosis. Hepatology 2008; 48 (6): 2064—2077.
- Runyon B.A. Practice Guidelines Committee, American Association for the Study of Liver Diseases (AASLD). Management of adult patients with ascites due to cirrhosis. Hepatology 2004; 39: 841—855. An update 2009.
- Plautha M., Cabre´b E., Riggioc O., Assis-Camilod M., Pirliche M., Kondrupf J. ESPEN Guidelines on Enteral Nutrition: Liver disease. Clin Nutrit 2006; 25: 285—294. doi: 10.1016/j.clnu.2006.01.018.
- Бакулин И.Г., Винницкая Е.В. Профилактика и лечение некоторых осложнений при циррозе печени. Эффективная фармакотер 2014;7: 12—21.
- Rimola A., García-Tsao G., Navasa M., Piddock L.J., Planas R., Bernard B., Inadomi J.M. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. J Hepatol 2000; 32: 142—153.
- Sort P., Navasa M., Arroyo V., Aldeguer X., Planas R., Ruiz-del-Arbol L., Castells L., Vargas V., Soriano G., Guevara M., Ginès P., Rodés J. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999; 341 (6): 403—409.
- Park F., Kravetz D. Ascites. San Diego: University of California 2010.
- Mehta R.L., Kellum J.A., Shah S.V., Molitoris B.A., Ronco C., Warnock D.G., Levin A. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11 (2): R31. doi: 10.1186/cc5713.
- Бакулин И.Г., Варламичева А.А. Гепаторенальный синдром: практические рекомендации по диагностике и лечению. Альманах клин мед 2014; 34: 23—31.
- Ginès P., Schrier R.W. Renal failure in cirrhosis. N Engl J Med 2009; 361 (13): 1279—1290.
- Moreau R., Lebrec D. The use of vasoconstrictors in patients with cirrhosis: type 1 HRS and beyond. Hepatology 2006; 43 (3): 385—394.
- Akriviadis E., Botla R., Briggs W., Han S., Reynolds T., Shakil O. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology 2000; 119 (6): 1637—1648.
Supplementary files
